Richard Pulik, an officer and director of Roivant Sciences Ltd., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 125,000 shares of common stock on NASDAQ.
Key Highlights
- Seller: Richard Pulik, identified in the filing as both an officer and a director of Roivant Sciences Ltd.
- Shares proposed for sale: 125,000 shares of common stock, with an aggregate market value of $5,150,575.00 as reported in the filing.
- Source of shares: The securities were acquired on November 10, 2026, through exercise of options under a registered plan, with cash payment on the same date.
- Broker named: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
- Shares outstanding: The filing reports 724,561,460 shares of common stock outstanding.
- Prior sales: The filing states nothing to report for securities sold during the past three months.
Richard Pulik's Proposed Share Sale at Roivant Sciences
According to the Form 144 notice filed on November 10, 2026, Richard Pulik intends to sell 125,000 shares of Roivant Sciences Ltd. (NASDAQ:ROIV) common stock. The aggregate market value of the proposed sale is listed as $5,150,575.00. The filing identifies Pulik as both an officer and a director of the issuer, and the sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.
The filing discloses that the 125,000 shares were acquired on November 10, 2026, via exercise of options under a registered plan, with the issuer named as the person from whom the securities were acquired. Payment was made in cash on the same date. The approximate date of sale is listed as November 10, 2026, the same date as the notice. The filing reports no securities sold by Pulik during the past three months.
As stated in the filing, Pulik represents by signing the notice "that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." Roivant Sciences Ltd. is listed on NASDAQ, with SEC file number 001-40782, and its issuer address is listed as 7th Floor, 50 Broadway, London, United Kingdom.
What Was Disclosed
Roivant Sciences officer and director Richard Pulik filed a Form 144 notice on November 10, 2026, proposing to sell 125,000 shares of common stock, acquired through option exercise, with an aggregate market value of $5,150,575.00, through Morgan Stanley Smith Barney LLC.






Please wait processing your request...